Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions
Ocular RosaceaPachychoroid Disease
Interventions
DIAGNOSTIC_TEST

Schirmer test paper

"This paper is centrifuged and your tears are collected then frozen before analysis. We collect the fat from your tears by scraping the edge of your lower eyelid with small sterile tweezers. All surgical waste will be collected during eye surgeries only if you must have them.~During each ocular surgical procedure, the vitreous, subretinal fluids and/or aqueous humor will eventually be recovered when required by the procedure. The rest of the blood samples, not used during diagnostic analyses, will be kept for later analyses.~Tears will be collected using a non-invasive and painless method that takes around ten minutes. The tissues (connectiva, cornea, retina, epi-retinal membrane) which must have been removed when required by the surgical procedure will also be preserved."

Trial Locations (1)

75679

RECRUITING

Departement of Ophthalmology, COCHIN Hospital, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Association CRO - Tous unis pour la vision

UNKNOWN

lead

Clinact

OTHER

NCT06466018 - Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort | Biotech Hunter | Biotech Hunter